Transfer factor therapy in immuno-deficiencies.
D000361:Agammaglobulinemia / Q000628:therapy; D000941:Antigens; D001260:Ataxia Telangiectasia / Q000628:therapy; D002175:Candida; D002179:Candidiasis, Cutaneous / Q000628:therapy; D006968:Hypersensitivity, Delayed; D007112:Immunity, Maternally-Acquired; D007116:Immunization, Passive; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D007167:Immunotherapy; D007962:Leukocytes / Q000276:immunology; D008213:Lymphocyte Activation; D009578:Nitrobenzenes; D012882:Skin Tests; D013299:Streptodornase and Streptokinase; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014374:Tuberculin Test; D014615:Vaccinia; D014923:Wiskott-Aldrich Syndrome / Q000628:therapy
D000941:Antigens; D009578:Nitrobenzenes; D014316:Tritium; D013299:Streptodornase and Streptokinase; D013936:Thymidine